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Abstract
Introduction Patients in intensive care units (ICUs) are generally
sedated for prolonged periods. Over-sedation and under-
sedation both have negative effects on patient safety and
resource use. We conducted a systematic review of the
literature in order to establish the incidence of sub-optimal
sedation (both over- and under-sedation) in ICUs.
Methods We searched Medline, Embase and CINAHL
(Cumulative Index to Nursing and Allied Health Literature) online
literature databases from 1988 to 15 May 2008 and hand-
searched conferences. English-language studies set in the ICU,
in sedated adult humans on mechanical ventilation, which
reported the incidence of sub-optimal sedation, were included.
All abstracts were reviewed twice by two independent
reviewers, with all conflicts resolved by a third reviewer, to check
that they met the review inclusion criteria. Full papers of all
included studies were retrieved and were again reviewed twice
against inclusion criteria. Data were doubly extracted. Study
aims, design, population, comparisons made, and data on the
incidence of sub-optimal, optimal, over-sedation or under-
sedation were extracted.
Results There was considerable variation between included
studies in the definition of optimal sedation and in the scale or
method used to assess sedation. Across all included studies, a
substantial incidence of sub-optimal sedation was reported,
with a greater tendency toward over-sedation.
Conclusions Our review suggests that improvements in the
consistent definition and measurement of sedation may improve
the quality of care of patients within the ICU.
Introduction
The majority of mechanically ventilated patients within the
intensive care unit (ICU) receive sedative drugs. Sedation is
administered to ensure patient comfort, reduce anxiety, and
facilitate treatments. Optimising sedation management is rec-
ognised as important in improving patient outcomes [1].
Under-sedated patients may become agitated and distressed
and are at risk of adverse events such as extubation [2-4],
whereas over-sedation can prolong time to recovery [1,5].
Assessment of sedation level is carried out mainly by nurses or
critical care physicians by assessing patient responses to sim-
ple stimuli. Sedation scales such as the Ramsay scale or the
Richmond Agitation-Sedation Scale (RASS) are widely used
[6-8]. However, there is no universally accepted standard, and
this can make comparison between different studies or ICUs
difficult [2]. Furthermore, some of these scales have not been
fully validated in ICU patients [4]. Recently, devices such as
the bispectral index monitor (BIS), which aim to assess seda-
tion levels more objectively, have been introduced. However,
most studies of BIS have been performed in surgical settings,
and to date its effectiveness is not fully proven [8-10].
Available guidelines on sedation typically provide limited guid-
ance on optimal sedation monitoring and levels. This is at least
partly because optimal sedation levels differ between patients
according to their clinical circumstances, and therefore seda-
tion practice is ideally individually tailored to each patient, as
recommended by several guidelines [2,11,12]. However,
among guidelines that do recommend an optimal level of
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sedation, there are discrepancies, indicating a lack of consen-
sus on this issue. For example, of a survey of available guide-
lines, one [13] recommended a sedation level of 2 or 3 on the
Ramsay scale, whereas one recommended a goal of RASS -3
for an intubated patient [14] and a second recommended a
goal of RASS 0 to -2 [15]. A number of guidelines stress the
importance of establishing a set protocol for the sedation of
ICU patients [16,17] but do not set out such a protocol in
detail, leaving it to individual institutions, and more recent
guidelines recognise the benefit of regular (daily) interruption
of sedation for eligible patients [11,14,18,19] within sedation
protocols.
It is recognised that optimising sedation practice is a recog-
nised quality marker for intensive care treatment, and proce-
dures designed to optimise patient sedation state, such as
daily sedation breaks and more frequent monitoring, are key
elements of recent quality improvement initiatives. However,
despite these recent efforts to improve the quality of sedation
practice in the ICU, the epidemiology of sedation, and specif-
ically the prevalence of over- or under-sedation, is unclear. To
investigate this further, we carried out a systematic review of
the publicly available literature to identify the reported inci-
dence of sub-optimal sedation.
Materials and methods
Searching
Medline, Embase and the Cumulative Index to Nursing and
Allied Health Literature (CINAHL) databases were searched
from 1988 to 15 May 2008 using terms for sedation, ICU,
sedation quality management, and sub-optimal sedation. The
standard Scottish Intercollegiate Guidance Network (SIGN)
filters for randomised controlled trials (RCTs), economic stud-
ies and observational studies [20] were combined to capture
all study designs relevant to the study question. Full details of
the search strategy used are available from the authors on
request. Conference proceedings from 2005 through 2008
were hand-searched for relevant studies. All results were
uploaded into a bespoke internet SQL (structured query lan-
guage)-based database.
Selection criteria
Inclusion of studies was according to a predetermined set of
criteria. To be included, studies had to be in adult humans who
were sedated and undergoing mechanical ventilation within
the ICU and furthermore had to report the incidence of sub-
optimal sedation, over- or under-sedation, or of optimal seda-
tion, as defined by the study. Studies that reported the impact
of sedation practice on outcomes were also included; these
data are reported separately. In addition, short-term studies
(including only patients sedated less than 24 hours) were
excluded. Only English-language studies were included. To
check that they met the review inclusion criteria, all abstracts
were reviewed twice by two independent reviewers, with all
conflicts resolved by a third reviewer. Full papers of all
included studies were retrieved and were again reviewed
twice to ensure that they met inclusion criteria. Studies
included at this stage were classified as to which aspect of the
review question they met, and appropriate data were
extracted, summarised and analysed.
Data extraction
Data were extracted by two reviewers and checked by a third
reviewer against the original studies. For all studies, the follow-
ing data were extracted: country, sponsor, study design,
patient population, objective, number of patients in the study,
details of comparisons made (such as between different treat-
ment arms or between different sedation monitoring systems),
and the proportion of measurements, patients, or time in which
patients were judged to be optimally sedated, sub-optimally
sedated, over-sedated, or under-sedated.
Quantitative data synthesis
Due to the wide range of included study types, no studies
were suitable for quantitative data synthesis.
Results
Systematic review study flow
The flow of studies through the systematic review is docu-
mented in the QUOROM (Quality of Reporting of Meta-Analy-
ses) diagram in Figure 1. Seventy-five primary and seven
secondary studies met the inclusion criteria. Of these, 18 did
not provide any data; either they did not contain data on the
outcomes extracted in this review or they did not provide these
data in quantitative form. Thirty-six studies reported data on
the incidence of sub-optimal sedation. The remainder reported
the impact of sedation practice on outcomes; these data are
reported separately. Of the included studies, three were
Figure 1
The QUOROM (Quality of Reporting of Meta-Analyses) diagram illus- trates the flow of studies through the systematic review The QUOROM (Quality of Reporting of Meta-Analyses) diagram illus-
trates the flow of studies through the systematic review.
2967 citations 
from literature 
databases
1964 citations 
excluded at 1st
pass
10 citations 
from 
conferences
88 citations 
excluded at 
2ndpass
2124 citations 
after eliminating 
duplicates
160 citations 
ordered for full-
text review 
82 citations 
included (75 
primary studies) 
36 studies reported 
incidence of inappropriate 
sedation; 3 secondary 
publications
18 studies reported impact 
of sedation practice on 
outcomes only; 4 
secondary publications
21 studies did not report 
any outcomes of interest
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cohort studies that specifically investigated the epidemiology
of sedation, 23 were studies investigating anaesthetic drugs
(of which 19 were RCTs and four were observational studies),
six studies compared sedation monitoring devices or scales
(of which one was an RCT and the remainder were observa-
tional studies), three studies investigated the introduction of
sedation guidelines, and one did not fit any of these catego-
ries. The majority of studies (20) were published after 2002,
indicating the increasing interest in the practice of sedation
quality in recent years, in particular following the publication of
updated sedation guidelines from the American College of
Critical Care Medicine [2,6].
Definitions of adequate sedation
To assess the incidence of sub-optimal sedation, it is neces-
sary to consider the definition of what constitutes optimal
sedation. We used the definition of optimal sedation (and con-
sequently of what constituted sub-optimal sedation) provided
by individual studies due to the fact that optimal sedation lev-
els will vary according to study setting (for example, between
neurological ICU and medical ICU).
Across all of the studies, 13 different sedation scales were
used to assess sedation quality; additionally, nurse assess-
ment of sedation quality simply as over-sedated, under-
sedated, or adequate was used three times (Table 1). The
Ramsay scale was the most commonly used scale, in 14 stud-
ies, with a variant used in a further 7 studies. This is illustrated
in Figure 2.
In addition to the variation in scales used to assess sedation,
there was variation in the recommended range of optimal
sedation levels stated. Sedation requirements obviously differ
among patients; nevertheless, the variation in recommended
ranges in included studies indicates some uncertainty in what
constitutes optimal sedation. Of the studies using the Ramsay
scale, recommended ranges were 2 to 3 (recommended in
two studies [21,22]), 2 to 4 (two studies [23,24]), 2 to 5 (two
studies [25,26]), 3 to 4 (two studies [27,28]) and 4 to 5 (one
study [29]), while three studies did not recommend specific
levels but recommended that levels be optimised for each indi-
vidual patient [30-32]. This variation was reflected in the other
scales used; for studies recommending a modified Ramsay
scale, recommended ranges were 1 to 4 [33], 3 to 4 [34], 4
[35], and 5 to 6 (the last range being specifically for seriously
injured patients [36]) or targets optimised for each patient
[37,38]. The stated SAS (Riker Sedation-Agitation Scale) tar-
get level was 1 to 3 [39], 4 [40,41], or 3 to 4 [42]. Due to the
number of studies recommending that optimal sedation state
be determined individually for each patient, there was no com-
parison possible for other scales.
Figure 2
The frequency with which each sedation scale was used in the studies included in our systematic review The frequency with which each sedation scale was used in the studies included in our systematic review. ICU, intensive care unit; MAAS, Motor 
Activity Assessment Scale; OAAS, Observer's Assessment of Alertness/Sedation Scale; RASS, Richmond Agitation Sedation Scale; SAS, Riker 
Sedation-Agitation Scale.
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Table 1
Incidence of optimal and sub-optimal sedation in included studies
Study Study design 
and 
comparisons 
made
Number Treatment arms 
(if relevant)
Incidence of 
sub-optimal 
sedation
Incidence of 
over-sedation
Incidence of 
under-sedation
Incidence of 
optimal sedation
Sedation scale/
monitoring 
system used
Definition of 
optimal sedation
Weinert, et al., 
2007 [44]
Cohort study 274 326 (2.6%) of 
12,414 
assessments.
111 patients 
(40%) had ≥ 1 
rating of over-
sedation. Patients 
were 
unarousable/
minimally 
arousable 32% of 
the time.
1,731 (13.9%) of 
12,414 
assessments.
211 (76.2%) had 
≥ 1 rating of 
under-sedation.
10,357 (83%) of 
12,414
Minnesota 
Sedation 
Assessment Tool 
-- nurse 
assessment
Arousal level 3-5 
(of 6-point scale)
Martin, et al., 
2006 [30]
Cohort study 305 (from 220 
ICUs)
42.6% of 49 
patients sedated 
24-72 hours, 
39.5% of 157 
patients sedated 
>72 hours, and 
43.9% of 57 
patients under 
weaning had 
significantly 
deeper sedation 
than desired level
5.2% of 157 
patients sedated 
>72 hours and 
3.5% of 57 
patients under 
weaning had 
significantly lower 
sedation than 
desired level
In patients 
sedated >72 
hours, the desired 
Ramsay score 
was 0-4 in 44% of 
cases -- this was 
achieved in 28%; 
in 55% of 
patients, the 
desired value was 
4-5, which was 
achieved in 68%; 
in 1% of patients, 
the desired score 
was 6, which was 
achieved in 6%.
Ramsay scale Individual to each 
patient
Payen, et al., 
2007 [43]
Cohort study 1,381 258 (57%) of 451 
patients on 
sedation day 2; 
169 (48%) of 355 
patients on day 4; 
109 (41%) of 266 
patients on day 6
Multiple: most 
commonly 
Ramsay, RASS, 
Sedation-
Agitation scale
Over-sedation 
defined as 
Ramsay 5-6, 
RASS -5 or --4, 
Sedation-
Agitation scale 1-
2
Sandiumenge, et 
al., 2000 [36]
RCT/
observational 
study of sedative 
drugs
63 Midazolam 19 (7%) of 266 
hours
247 (93%) of 266 
hours
Modified Ramsay 
scale
Equivalent of 
Ramsay 5-6 (for 
deep sedation)
2% propofol 14 (9%) of 156 
hours
142 (91%) of 156 
hours
Carrasco, et al., 
1993 [26]
RCT (with 
economic study) 
of sedative drugs
88 Midazolam 18% of time 
(hours)
82% of time 
(hours)
Ramsay scale; 
Glasgow coma 
scale (modified by 
Cook and Palma)
Ramsay scale 2-5, 
Glasgow coma 
scale 8-13C
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Propofol 7% of time 
(hours)
93% of time 
(hours)
McCollam, et al., 
1999 [23]
RCT of sedative 
drugs
30 Lorazepam 32% of 
assessments
14% of 
assessments
18% of 
assessments
68% of 
assessments
Ramsay scale Ramsay scale 2-4
Midazolam 21% of 
assessments
6% of 
assessments
16% of 
assessments
79% of 
assessments
Propofol 38% of 
assessments
7% of 
assessments
31% of 
assessments
62% of 
assessments
Chinachoti, et al., 
2002 [40]
RCT of sedative 
drugs
152 Remifentanil 28% of patients; 
17.3% of time 
(hours)
13% of time 
(hours)
4% of time 
(hours)
78% of patients 
(without 
midazolam), 83% 
of time (hours) 
(maintenance 
phase)
SAS SAS 4 with no or 
mild pain
Morphine 27% of patients; 
16% of time 
(hours)
13% of time 
(hours)
3% of time 
(hours)
73% of patients 
(without 
midazolam), 84% 
of time (hours) 
(maintenance 
phase)
Harper, et al., 
1991 [25]
RCT of sedative 
drugs
37 Alfentanil low, 
moderate and 
high doses -- 
results reported 
together
4 patients had 
>10% of time at 
sedation level 6
3 patients had 
>10% of time at 
sedation level 1
Ramsay 
(assessed hourly)
2-5
Manley, et al., 
1997 [46]
RCT (and 
economic study) 
of sedative drugs
26 Morphine + 
midazolam
56.8% of time 43.2% of time North 
Staffordshire ICU 
(modification of 
Ramsay/
Addenbrooke's 
scores)
3-4
Alfentanil + 
propofol
57.8% of time 42.2% of time
Millane, 1992 
[21]
RCT of sedative 
drugs
24 Isoflurane for 24 
hours followed by 
propofol
3.4% Ramsay plus 
subjective nurse 
assessment
2-3 (plus 
subjective nurse 
assessment)
Propofol for 24 
hours followed by 
isoflurane
3.6%
Muellejans, et al., 
2004 [41]
RCT of sedative 
drugs
152 Remifentanil 11.7% of time 
(hours)
88.3% of time 
(hours)
SAS 4
Fentanyl 10.7% of time 
(hours)
89.3% of time 
(hours)
Table 1 (Continued)
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Muellejans, et al., 
2006 [47]
RCT of sedative 
drugs
80 Remifentanil -- 
propofol
41% of time 28% of time 13% of time 59% of time 3 level sedation 
score specific to 
study
Level 2
Midazolam -- 
fentanyl
30% of time 19% of time 11% of time 70% of time
Chamorro, et al., 
1996 [45]
RCT of sedative 
drugs
98 Propofol 332 assessments 
-- 3% (after first 
hour)
332 assessments 
-- 76.5% effective, 
20.5% 
acceptable
Study-specific 
(modified 
Glasgow coma 
scale). Patients 
monitored at 1 
and 6 hours and 
then every 12 
hours.
4 = effective, 3 = 
acceptable
less than 3 = 
ineffective
Midazolam 355 assessments 
-- 7.6%
355 assessments 
-- 66.2% effective, 
26.2% 
acceptable
Barr, et al., 2001 
[34]
RCT of sedative 
drugs
24 Lorazepam 51% of time 47% of time 49% of time Modified Ramsay 3-4 (5-6 = over-
sedation)
Midazolam 31% of time 22% of time 69% of time
Finfer, et al., 1999 
[33]
RCT of sedative 
drugs
40 Diazepam 
(intermittent)
9 (64.3%) of 14 
patients; 15.0% 
of time (hours)
2.8% of time 
(hours)
21.1% of time 
(hours)
5 (35.7%) of 14 
patients;
85.0% of time 
(hours)
Modified Ramsay 1-4
Midazolam 
(continuous)
6 (35.3%) of 17 
patients; 40.8% 
of time (hours)
14.8% of time 
(hours)
0% of time 
(hours)
11 (64.7%) of 17 
patients;
59.2% of time 
(hours)
Richman, et al., 
2006 [37]
RCT of sedative 
drugs
30 Midazolam Mean 9.1 hours/
day (SD 4.9)
Modified Ramsay Individual to each 
patient
Midazolam and 
fentanyl
Mean 4.2 hours/
day (SD 2.4)
Karabinis, et al., 
2004 [39]
RCT of sedative 
drugs
161 Remifentanil 4.4% of time 95.6% of time 
(median)
SAS 1-3
Fentanyl 1.9% of time 98.1% of time 
(median)
Morphine 1.0% of time 99.0% of time 
(median)
Pandharipande, et 
al., 2007 [48], 
Pandharipande, et 
al., 2006 [59]
RCT of sedative 
drugs
106 Dexmedetomidine 20% of patients 
according to 
nurse goals; 33% 
according to 
physician goals
15% of patients 80% of patients 
within 1 point of 
nurse goal; 67% 
within 1 point of 
physician goal
RASS, confusion-
assessment 
method for the 
ICU (CAM-ICU)
Individual to each 
patient
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Lorazepam 33% of patients 
according to 
nurse goals; 45% 
according to 
physician goals
33% of patients 67% within 1 
point of nurse 
goal; 55% within 
1 point of 
physician goal
Swart, et al., 
1999 [50]
RCT of sedative 
drugs
64 Lorazepam 13% of time 87.0% of time 
(SD 10.5)
Addenbrooke's 
Hospital's ICU 
sedation scale
Individual to each 
patient
Midazolam 34% of time 66.2% of time 
(SD 23.1)
Carson, et al., 
2006 [22]
RCT of sedative 
drugs
132 Intermittent 
lorazepam
42.8% (ventilator 
hours)
37.9% (ventilator 
hours)
15.1% (ventilator 
hours)
Ramsay 2-3
Continuous 
propofol
49.9% (ventilator 
hours)
38.6% (ventilator 
hours)
11.5% (ventilator 
hours)
Anis, et al., 2002 
[31], Hall, et al., 
2001 [60]
RCT of sedative 
drugs
156 Propofol 39.8% of time 12.0% of time 11.2% of time 60.2% of time Ramsay Individual to each 
patient
Midazolam 56.0% of time 18.4% of time 8.1% of time 44.0% of time
Park, et al., 2007 
[49]
RCT of sedative 
drugs
134 (111 
analysed)
Analgesia-based 
sedation
50% of time 50% of time on 
SIMV (median)
Assessor 
judgement
Adequate judged 
as awake or easily 
rousable
Hypnotic-based 
sedation
81% of time 19% of time on 
SIMV (median)
Cigada, et al., 
2005 [32]
Observational 
study of sedative 
drugs
42 Propofol or 
midazolam with 
enteral 
hydroxyzine with 
or without 
supplemental 
lorazepam. IV 
drugs were 
tapered after 48 
hours.
36.9% of 
assessments as 
judged by Ramsay 
score; 17% by 
nurse assessment
421 (24.6%) of 
1,711 
assessments 
(Ramsay score)
42 (7.3%) of 577 
assessments 
(nurse judgement)
211 (12.3%) of 
1,711 
assessments 
(Ramsay score)
56 (9.8%) of 577 
assessments 
(nurse judgement)
1,079 (63.1%) of 
1,711 
assessments 
(Ramsay score)
479 (83%) of 577 
assessments 
(nurse judgement)
Ramsay score 
plus nurse 
assessment
Adequate 
sedation defined 
as the 
achievement of 
the planned 
Ramsay score or 
nurse judgement 
as adequate
Barrientos-Vega, 
et al., 2001 [29]
Observational 
study of sedative 
drugs
51 2% propofol 
(compared with 
historical cohort 
on 1% propofol -- 
not reported here)
8 (15.6%) of 51 
patients judged 
therapeutic failure 
on 2% propofol 
(inadequate level 
of sedation)
Ramsay score 4-5
MacLaren, et al., 
2007 [42]
Observational 
study of sedative 
drugs
40 Dexmedetomidine 
as adjunct to 
lorazepam/
midazolam/
propofol
35% of patients 
with 
dexmedetomidine; 
52% without
12 (30%) patients 
with 
dexmedetomidine; 
9 (23%) without
4 (10%) patients 
with 
dexmedetomidine; 
12 (30%) without
65% of patients 
with 
dexmedetomidine; 
48% without
SAS 3-4
Table 1 (Continued)
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Shehabi, et al., 
2004 [24]
Observational 
study of sedative 
drugs
20 Dexmedetomidine 
with supplemental 
midazolam if 
required
455 (33%) of 
1,381 
assessments
97 (7%) of 1,381 
assessments 
were Ramsay 
level 6
137 (10%) of 
1,381 
assessments 
were Ramsay 
level 1
926 (67%) of 
1,381
Ramsay 2-4
Sackey, et al., 
2004 [51]
RCT of sedation 
devices
40 Isoflurane using 
AnaConDa
46% of time; 
nursing staff 
estimate 11% of 
time
44% of time 2% of time 54% of time;
nursing staff 
estimate 89% of 
time
Bloomsbury scale - 1 to +1
IV midazolam 41%; nursing staff 
estimate 13% of 
time
37% of time 4% of time 59% of time; 
nursing staff 
estimate 87% of 
time
Walsh, et al., 
2008 [52]
Observational 
study of sedation 
devices
30 All sedated 
patients
137 (32.9%) of 
416 assessments 
(Ramsay score 5-
6)
5 (1.2%) of 416 
assessments 
(Ramsay score 1)
Entropy Module/
Modified Ramsay 
scale
None stated. 
Refers to 
guidelines 
suggesting 2-3 is 
adequate and 
heavy/over-
sedated is 5-6.
Hernández-
Gancedo, et al., 
2006 [28]
Observational 
study of sedation 
scales
50 44% (66 cases) -- 
Ramsay level 6
25% (38 cases) Ramsay, 
Observer's 
Assessment of 
Alertness and 
Sedation
Ramsay 3-4
Roustan, et al., 
2005 [27]
Observational 
study of sedation 
scales
40 All sedated 
patients -- treated 
with midazolam 
and morphine
93 (61.6%) of 
151 records
19 (12.6%) of 
151 records
Ramsay, Comfort 
score, EEG
Ramsay 3-4
McMurray, et al., 
2004 [38]
Observational 
study of sedation 
scales
122 Propofol-
containing 
regimens
15.6% of time Mean 5.0% of 
time (SD 12.7)
Mean 10.6% of 
time (SD 14.5)
Mean 84.4% of 
time (SD 18.0)
Modified Ramsay Individual to each 
patient
Detriche, et al., 
1999 [53]
Before-after study 
of introduction of 
sedation protocol
55 Before 20 (30%) of 67 
assessment days
Brussels sedation 
scale
3-4
After protocol 
introduction
9 (12%) of 77 
assessment days
Costa, et al., 
1994 [54]
RCT of controlled 
and empirical 
sedation
40 Controlled 17% of time 83% of time Ramsay, and 
Glasgow coma 
scale modified by 
Cook and Palma
Empirical 65% of time 35% of time
MacLaren, et al., 
2000 [35]
Before-after 
comparison of 
sedation protocol
158 Before 22.4% 
(experience of 
anxiety or pain)
Modified Ramsay 4
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After 11.0% (P < 
0.001)
Tallgren, et al., 
2006 [3]
Before-after 
comparison of 
sedation protocol
53 Before 
reinforcement
Median Ramsay 
level was 4 during 
the day and 5 at 
night, in contrast 
to the study's 
stated aim of 
Ramsay level 2-3 
during the day 
and 3-4 at night
Ramsay
After 
reinforcement
Median Ramsay 
level was 4 during 
the day and 5 at 
night, in contrast 
to the study's 
stated aim of 
Ramsay level 2-3 
during the day 
and 3-4 at night
Samuelson, et al., 
2007 [61], 
Samuelson, et al., 
2006 [62]
Observational 
study
250 50% of patients 
had MAAS 0-2 
(although 2 was 
target for study, 0-
1 could be viewed 
as over-sedated)
0% 39% of patients 
achieved MAAS 3 
in ventilated 
period
MAAS Stated 2-3 but 
results reported 
for patients 
achieving 3
EEG, electroencephalogram; ICU, intensive care unit; IV, intravenous; MAAS, Motor Activity Assessment Scale; RASS, Richmond Agitation-Sedation Scale; RCT, randomised controlled trial; SAS, Riker 
Sedation-Agitation Scale; SD, standard deviation; SIMV, synchronised intermittent mandatory ventilation.
Table 1 (Continued)
Incidence of optimal and sub-optimal sedation in included studiesCritical Care    Vol 13 No 6    Jackson et al.
Page 10 of 14
(page number not for citation purposes)
Incidence of sub-optimal sedation
Table 1 lists the study design, sedation assessment scale or
tool used, and incidence of sub-optimal sedation reported by
studies. As stated above, we used individual study definitions
of optimal and sub-optimal sedation because of the fact that
optimal sedation levels are likely to vary by study setting.
The three observational studies that investigated the epidemi-
ology of sedation were considered to be the most relevant to
the study question as their specific aim was to investigate clin-
ical sedation practice rather than practice within the confines
of a trial, where more frequent monitoring and the Hawthorne
effect could contribute to improving standards.
A survey of practice across 44 ICUs in France also found a
high incidence of deep sedation, in 41% to 57% of readings
over a 6-day period [43]. This study highlighted the risks of
prolonged deep sedation, which, however, was not specifi-
cally defined as over-sedation. Results from these three stud-
ies indicate that 30% to 60% of sedation assessments
indicate 'deep' or 'over' sedation, although precise description
of the prevalence is confounded by imprecise definition or
health care worker perceptions. These studies clearly indicate
an excess of over-sedation compared with under-sedation.
Martin and colleagues [30] conducted a postal survey of 220
ICUs in Germany. This study found that 42.6% of patients
sedated between 24 and 72 hours and 39.5% of patients
sedated over 72 hours were over-sedated; the incidence of
under-sedation was much lower (<6%).
In the US-based study of Weinert and colleagues [44], the aim
was to compare subjective and objective ratings of sedation.
Subjects provided 12,414 sedation assessments and were
judged by nurses to be sub-optimally sedated in 17% of
assessments, over-sedated in 2.6%, and under-sedated in
13.9%. Critically, however, patients were unrousable or mini-
mally rousable just under one third of the time, indicating a
high incidence of deep sedation. This finding illustrates the
importance of the perception of the health care worker or
assessor or both in describing the prevalence of sub-optimal
sedation.
The remaining included studies comprised studies of sedative
drugs [21-26,29,31-34,36,37,39-42,45-50], studies investi-
gating different sedation devices or scales [27,28,38,51,52],
and studies looking at the introduction of a sedation guideline
or protocol [3,35,53,54]. Studies varied by design and aim, by
sedatives used, by scales and definitions of sub-optimal seda-
tion used, and by the way incidence was reported (as a pro-
portion of measurements, patients, or time). While these
studies did not necessarily have the incidence of sub-optimal
sedation as their primary focus, the data in such studies were
considered to be of interest to the inclusive scope of this
review. Although studies of sedative drugs or of the introduc-
tion of guidelines or protocols may not give an accurate esti-
mate of the incidence of sub-optimal sedation within routine
clinical practice, they nevertheless show that it does occur and
can give an impression of the extent to which it may be a prob-
lem, even in settings that could be reasonably expected to be
more controlled than in routine practice. The incidence of sub-
optimal sedation reported in these studies is summarised in
Figure 3 (separated by study and treatment arm where rele-
vant). The reported incidence varied from 1% [39] to 75%
[28], with the majority reporting an incidence of over 20%. The
incidence of over- and under-sedation was similarly variable,
and figures of between 2.8% and 44% for over-sedation
[28,33,51] and between 2% and 31% for under-sedation
[23,51] were reported. A further study [2] that looked at the
introduction of a sedation guideline did not record the inci-
dence of sub-optimal sedation but recorded the median Ram-
say scale values. These were 4 during the day and 5 at night,
in contrast to the study's stated aim of Ramsay levels of 2 to 3
during the day and 3 to 4 at night; this study again noted a
possible tendency toward over-sedation of patients. Impor-
tantly, there was no change in this tendency before and after
reinforcement of the guideline, suggesting that this was insuf-
ficient to improve sedation practice [3].
Discussion
Our systematic review identified few studies that specifically
described the epidemiology of sedation during ICU care.
Description of the incidence of sub-optimal sedation and over-
and under-sedation was difficult due to variation in the use of
these terms within individual studies. Overall, available data
suggest a high incidence of over-sedation in ICUs, potentially
present at 40% to 60% of assessments. A lower reported inci-
dence of sub-optimal sedation across most studies suggests
that health care workers consider deep levels of sedation
appropriate for many patients.
The quality of published studies was low. There was wide var-
iation in the method used to assess sedation state, the fre-
quency of measurement, and the stated response to
evaluations. In addition, the completeness of data in relation to
entire ICU populations was usually not stated, introducing the
potential for selection bias. Only three cohort studies were
found. The importance of selection or inclusion bias was low-
est with this study design. All of these indicated a substantial
incidence of sub-optimal sedation, with over-sedation being
more common (33% to 57%). Notably, one study reported
that nurse assessment of sedation found a low incidence of
over-sedation, which appeared at odds with the fact that in
one third of measurements patients were unrousable or mini-
mally rousable. A difference in perceptions of what constitutes
optimal sedation between different health care worker groups
and between individual health care workers is also likely to
affect the reported incidence of sub-optimal sedation. This
finding emphasises the importance of using sedation-assess-
ment methods that have high validity and low inter-rater varia-Available online http://ccforum.com/content/13/6/R204
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bility. Many of the scales in current use have not been
subjected to formal evaluation. The RASS has been shown to
have good construct validity and high levels of consistency
among health care workers [55] but was used infrequently in
the published literature.
When non-cohort studies were considered, a wide range of
incidence of sub-optimal sedation levels was reported (from
1% to 75%). These studies were randomised or non-ran-
domised trials of the efficacy of sedative drugs [21-26,29,31-
34,36,37,39-42,45-50], or were studies that evaluated seda-
tion devices or scales [27,28,38,51,52] to monitor sedation
levels, or looked at the introduction of sedation guidelines
[3,35,53,54]. Overall, the chance of selection and investigator
bias, and of study effects, in these studies was high. Drug trials
in particular were considered less relevant to our study ques-
tion as practice within a clinical trial may differ from standard
care and is more likely to be controlled. Despite these factors,
the majority of studies found an incidence of sub-optimal seda-
tion, using study-specific definitions, of greater than 20%.
These studies confirm the findings of the observational cohort
studies and suggest high levels of sub-optimal sedation during
routine care.
Improving sedation management through sedation protocols
and interventions such as daily interruption of sedation is an
increasing focus of quality improvement initiatives in critical
care in some health care systems [1,56,57]. Sedation proto-
cols and scales are increasingly, though not universally, used.
A review of German hospitals by Martin and colleagues [6]
showed increases in the use of sedation protocols (from 21%
of hospitals to 46%) and in the use of sedation scales (from
8% to 51%) over the period of 2002 to 2006. In Finland, Tall-
gren and colleagues [3] reported that reinforcing a sedation
guideline increased the percentage of expected Ramsay scale
recordings made, but only to 71% of expected recordings that
were actually made, indicating that formal sedation assess-
ments were still not carried out as regularly as they should
have been. These studies suggest that, despite recent evi-
dence supporting the avoidance of over-sedation [57,58], the
use of systematic approaches to measure sedation state and
optimise sedation for individual patients is not universal. The
high prevalence of sub-optimal sedation and high incidence of
over-sedation in published studies indicate potential for signif-
icant quality improvement in this aspect of care. This is likely to
translate into substantial patient benefit.
There are several limitations to our review. As with any system-
atic review, studies may have been missed; this review was
Figure 3
Incidence of sub-optimal sedation across included studies Incidence of sub-optimal sedation across included studies. The plot shows the percentage of measurements, patients, or time in which patients 
were sub-optimally sedated according to each included study's definition of optimal sedation and measurements reported. Studies are grouped by 
study design. Where more than one group was reported by a study (for example, a comparison of two different treatment arms), separate points are 
shown for each group. RCT, randomised controlled trial.
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confined to English-language publications and therefore may
be biased toward the US and UK in focus. Despite the inclu-
sion of conference searching, there may be relevant grey liter-
ature that we did not search. As previously discussed, many of
the included studies did not investigate the quality of sedation
practice as their primary aim, limiting the relevance of the infor-
mation provided.
Conclusions
Our review indicates the poor quality of epidemiological data
concerning current sedation practice and the incidence of
sub-optimal sedation. A key issue is the standardisation of
methods of assessment and definitions of optimal sedation.
Despite this, available data suggest that many patients in ICUs
are considered sub-optimally sedated and, specifically, that
the incidence of over-sedation remains high. The strong asso-
ciations between sedation practice, especially over-sedation,
and adverse patient outcomes suggest that a more uniform
approach to monitoring depth and quality of sedation will
improve quality of care.
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